Access the full text.
Sign up today, get DeepDyve free for 14 days.
Satomi Takahashi, H. Uchino, Tomoaki Shimizu, A. Kanazawa, Y. Tamura, Ken Sakai, H. Watada, T. Hirose, R. Kawamori, Yasushi Tanaka (2007)
Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.Endocrine journal, 54 1
E. Selvin, M. Steffes, C. Ballantyne, R. Hoogeveen, J. Coresh, F. Brancati (2011)
Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based DataAnnals of Internal Medicine, 154
K. Borch-Johnsen, A. Neil, B. Balkau, S. Larsen, A. Nissinen, J. Pekkanen, S. Keinänen-Kiukaanniemi, L. Hiltunen, S. Kivelä, J. Tuomilehto, P. Jousilahti, J. Lindstrom, M. Pyorala, K. Pyörälä, E. Eschwège, G. Gallus, M. Garancini, A. Schranz, R. Heine, J. Dekker, E. Feskens, H. Lithell, B. Zethelius, M. Peltonen, N. Unwin, N. Ahmad, K. Alberti, M. Alberti, J. Eriksson, Q. Qiao (1999)
Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 354
M. Koga, J. Murai, H. Saito, M. Otsuki, S. Kasayama (2011)
Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathyDiabetology International, 2
(1995)
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications TrialDiabetes, 44
J. Chiasson, R. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso (2003)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.JAMA, 290 4
D. Nathan, M. Steffes, Wanjie Sun, G. Rynders, J. Lachin (2011)
Determining stability of stored samples retrospectively: the validation of glycated albumin.Clinical chemistry, 57 2
K. Yoshiuchi, M. Matsuhisa, N. Katakami, Y. Nakatani, K. Sakamoto, T. Matsuoka, Y. Umayahara, K. Kosugi, H. Kaneto, Y. Yamasaki, M. Hori (2008)
Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.Endocrine journal, 55 3
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
Lin Lu, L. Pu, X. Xu, Qi Zhang, R. Zhang, Jian Zhang, Jian Hu, Zheng-kun Yang, A. Lu, F. Ding, Jie Shen, Qiujing Chen, Sheng Lou, Dan-hong Fang, W. Shen (2007)
Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.Clinical biochemistry, 40 11
(1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet, 352
I Takei (2008)
JSCC recommended method for glycated albumin measurement in serumJpn J Clin Chem, 37
Y. Tahara (2009)
Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model.Diabetes research and clinical practice, 84 3
E. Selvin, Lesley Francis, C. Ballantyne, R. Hoogeveen, J. Coresh, F. Brancati, M. Steffes (2011)
Nontraditional Markers of GlycemiaDiabetes Care, 34
Yasuo Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, Sadatoshi Motoyoshi, Yujiro Kojima, N. Furuyoshi, M. Shichiri (1995)
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.Diabetes research and clinical practice, 28 2
M. Koga, Soeko Matsumoto, H. Saito, S. Kasayama (2006)
Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients.Endocrine journal, 53 3
A. Geistanger, S. Arends, C. Berding, T. Hoshino, J. Jeppsson, R. Little, C. Siebelder, C. Weykamp (2008)
Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.Clinical chemistry, 54 8
L. Tsai, S. Tsai, M. Lin, S. Liu (2001)
Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat).Clinical chemistry, 47 4
Saul Genuth (1995)
The case for blood glucose control.Advances in internal medicine, 40
Ernst Schaefer, M. Audelin, J. Mcnamara, Paulesh Shah, Timothy Tayler, J. Daly, Joi Augustin, Leo Seman, Joel Rubenstein (2001)
Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease.The American journal of cardiology, 88 10
C. Guthrow, M. Morris, James DAYt, Suzanne THORPEt, John BAYNEStt (1979)
Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus.Proceedings of the National Academy of Sciences of the United States of America, 76 9
H. Ohnishi, Y. Sawayama, N. Furusyo, S. Maeda, S. Tokunaga, J. Hayashi (2010)
Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS).Journal of atherosclerosis and thrombosis, 17 7
M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, A. Sekikawa (1999)
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.Diabetes care, 22 6
D. Nathan, B. Balkau, E. Bonora, K. Borch-Johnsen, J. Buse, S. Colagiuri, M. Davidson, R. DeFronzo, S. Genuth, R. Holman, L. Ji, S. Kirkman, W. Knowler, D. Schatz, J. Shaw, E. Sobngwi, M. Steffes, O. Vaccaro, N. Wareham, B. Zinman, R. Kahn (2009)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 32
(2009)
International committee report on the role of the A1c assay in the diagnosis of diabetes. ADA Workgroup reportDiabetes Care, 32
E Selvin, LM Francis, CM Ballantyne (2011)
Nontraditional markers of glycemia: associations with microvascular conditionsDiabetes Care, 34
B. Freedman, Z. Shihabi, L. Andries, Cesar Cardona, T. Peacock, J. Byers, G. Russell, R. Stratta, A. Bleyer (2010)
Relationship between Assays of Glycemia in Diabetic Subjects with Advanced Chronic Kidney DiseaseAmerican Journal of Nephrology, 31
M Tominaga, H Makino, G Yoshino (2006)
Report of the committee on standardization of laboratory testing related to diabetes mellitus of Japan Diabetes Society: determination of reference intervals of hemoglobin A1c (IFCC) and glycoalbumin in the Japanese populationJ Japan Diab Soc, 49
Tomoko Suwa, Akio Ohta, Tomoya Matsui, Rieko Koganei, H. Kato, Takehiro Kawata, Y. Sada, S. Ishii, Akihiko Kondo, K. Murakami, T. Katabami, Yasushi Tanaka (2010)
Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).Endocrine journal, 57 2
T. Kouzuma, Tomomi Usami, M. Yamakoshi, Mamoru Takahashi, S. Imamura (2002)
An enzymatic method for the measurement of glycated albumin in biological samples.Clinica chimica acta; international journal of clinical chemistry, 324 1-2
R. Turner, C. Fox, Matthews, H. Mcelroy, C. Cull, R. Holman, P. Neil, D. Hadden, D. Wright, É. Manley, I. Stratton, Uk Diabetes, E. Kohner, Frighi, Michael Gnant (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.The Lancet
(1999)
Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in EuropeLancet, 354
M. Ai, S. Otokozawa, E. Schaefer, B. Asztalos, K. Nakajima, P. Shrader, S. Kathiresan, J. Meigs, G. Williams, D. Nathan (2009)
Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus.Clinica chimica acta; international journal of clinical chemistry, 406 1-2
There is merit to further investigating the potential for glycated albumin to be used as an alternative measure of dysglycaemia for future research and clinical practice.
Diabetologia – Springer Journals
Published: Dec 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.